ORIGINAL ARTICLE
Optimising the management of patients with multiple myeloma in Spain: A measurement of the social return on investment
María Merino,
Yoana Ivanova, Paulina Maravilla-Herrera, Begoña Barragán,
Jordi Sierra,
Ángeles Peñuelas-Saiz,
Álvaro Hidalgo-Vega,
Corresponding Author
María Merino
Fundación Weber, Madrid, Spain
Correspondence
María Merino, Calle Moreto, 17, 5D, Madrid 28014, Spain.
Email: [email protected]
Search for more papers by this authorBegoña Barragán
AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia, Madrid, Spain
Search for more papers by this authorJordi Sierra
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Search for more papers by this authorÁngeles Peñuelas-Saiz
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Vall d'Hebron Institute of Oncology, Barcelona, Spain
Search for more papers by this authorÁlvaro Hidalgo-Vega
Fundación Weber, Madrid, Spain
Universidad de Castilla-La Mancha, Toledo, Spain
Search for more papers by this authorMaría Merino,
Yoana Ivanova, Paulina Maravilla-Herrera, Begoña Barragán,
Jordi Sierra,
Ángeles Peñuelas-Saiz,
Álvaro Hidalgo-Vega,
Corresponding Author
María Merino
Fundación Weber, Madrid, Spain
Correspondence
María Merino, Calle Moreto, 17, 5D, Madrid 28014, Spain.
Email: [email protected]
Search for more papers by this authorBegoña Barragán
AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia, Madrid, Spain
Search for more papers by this authorJordi Sierra
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Search for more papers by this authorÁngeles Peñuelas-Saiz
Hospital Universitari Vall d'Hebron, Barcelona, Spain
Vall d'Hebron Institute of Oncology, Barcelona, Spain
Search for more papers by this authorÁlvaro Hidalgo-Vega
Fundación Weber, Madrid, Spain
Universidad de Castilla-La Mancha, Toledo, Spain
Search for more papers by this authorFirst published: 30 September 2022
This work was supported by Amgen S.A., which had no involvement in the design of the study; collection, analysis and interpretation of data; and writing of the manuscript.
Funding information: Amgen
Abstract
Objective
The aim of this study was to reach a consensus on a set of proposals to optimise the disease management of Multiple myeloma (MM) within the Spanish National Health System (SNHS) and to apply the Social Return on Investment (SROI) method to estimate their social impact.
Methods
A Multidisciplinary Working Team (MWT) including MM main stakeholders was organised. A survey was administered to gather information from patients regarding the impact of MM on different life domains. A forecast-type SROI analysis, with a 1-year timeframe, was applied.
Results
Fifteen proposals were selected, to optimise MM management, including actions for early diagnosis, psychological support, improvement of information for patients and quick access to palliative care, among others. The implementation of these proposals would benefit patients, their informal caregivers and the SNHS. The investment required would amount to 10.32 million euros with a social return of 43.31 million euros: 4.2 euros for each euro invested. According to the sensitivity analysis, this ratio could range from 3.38 to 5.20 euros from the worst to the best-case scenario.
Conclusions
The current management of MM could be optimised by implementing a set of proposals that would most likely result in an overall positive social return.
CONFLICT OF INTEREST
The Haematology Service where JS works has received funding from Amgen for the development of educational activities. JS has received fees from Amgen for his participation as an expert in different advisory boards. The remaining authors have no conflict of interest to declare.
Open Research
DATA AVAILABILITY STATEMENT
Data relevant to the study are included in the article or uploaded as supporting information. Additional data will be made available upon reasonable request to the corresponding author.
Supporting Information
| Filename | Description |
|---|---|
| ecc13706-sup-0001-Supporting information 1.docxWord 2007 document , 1.8 MB |
Supporting information S1. Multiple myeloma patient survey |
| ecc13706-sup-0002-Supporting information 2.docxWord 2007 document , 2 MB |
Supporting information S2. Proposal breakdown and analysis |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia. (2015). Informe 2015 de Necesidades de Los Pacientes Con Mieloma Múltiple y Sus Familiares En España. AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia.
- AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia. (2017). Informe de Recomendaciones Para La Atención de Calidad Del Mieloma Múltiple. Asociación Española de Afectados por Linfoma, Mieloma y Leucemia.
- Ashcroft, J., Duran, I., Hoefeler, H., Lorusso, V., Lueftner, D., Campioni, M., Intorcia, M., & Bahl, A. (2018). Healthcare resource utilisation associated with skeletal-related events in European patients with multiple myeloma: Results from a prospective, multinational, observational study. European Journal of Haematology, 100(5), 479–487. https://doi.org/10.1111/ejh.13044
- Banke-Thomas, A. (2018). What about the issues in using social return on investment as an evaluation tool? Evaluation Journal of Australasia, 18(1), 64–68. https://doi.org/10.1177/1035719X17753984
10.1177/1035719X17753984 Google Scholar
- Banke-Thomas, A. O., Madaj, B., Charles, A., & van den Broek, N. (2015). Social return on investment (SROI) methodology to account for value for money of public health interventions: A systematic review. BMC Public Health, 15(1), 582–595. https://doi.org/10.1186/s12889-015-1935-7
- Banke-Thomas, A., Madaj, B., Kumar, S., Ameh, C., & van den Broek, N. (2017). Assessing value-for-money in maternal and newborn health. BMJ Global Health, 2(2), e000310. https://doi.org/10.1136/bmjgh-2017-000310
- Blimark, C., Holmberg, E., Mellqvist, U.-H., Landgren, O., Björkholm, M., Hultcrantz, M., Kjellander, C., Turesson, I., & Kristinsson, S. Y. (2015). Multiple myeloma and infections: A population-based study on 9253 multiple myeloma patients. Haematologica, 100(1), 107–113. https://doi.org/10.3324/haematol.2014.107714
- Brioli, A., Klaus, M., Sayer, H., Scholl, S., Ernst, T., Hilgendorf, I., Scherag, A., Yomade, O., Schilling, K., Hochhaus, A., Mügge, L.-O., & von Lilienfeld-Toal, M. (2019). The risk of infections in multiple myeloma before and after the advent of novel agents: A 12-year survey. Annals of Hematology, 98(3), 713–722. https://doi.org/10.1007/s00277-019-03621-1
- Carretero, G., Moreno, D., Domínguez, A. G., Trigos, D., Ledesma, A., Sarquella, E., Merino, M., Blanch, C., & SROI Psoriasis Group. (2020). Multidisciplinary approach to psoriasis in the Spanish National Health System: A social return on investment study. Global & Regional Health Technology Assessment, 7(1), 50–56. https://doi.org/10.33393/grhta.2020.2146
- de Castro Carpeño, J., Pérez, J. L. F., Barragán, P. L., Dols, M. Á. C., Gil, J. M., Mena, A. C., Puentes, Á. F., Palomo, A. G., Mateu, M. M., Soler, M. J. C., Saiz, M. Á. P., García, J. P., & Pinyol-i-Villena, C. (2018). Cuantificando El Beneficio de La Sustitución Por Vinorelbina Oral En Los Pacientes Susceptibles de Tratamiento Con Vinorelbina. Estudio Del Retorno Social de La Inversión. Revista Española de Economía de La Salud, 13(2), 336–353.
- Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., Torrance, G. W., & Stoddart, G. L. (2015). Methods for the economic evaluation of health care programmes ( 4th ed.). Oxford University Press.
- Emerson, J., & Cabaj, M. (2000). Social return on investment. Making Waves, 11(2), 10–14.
- Ernst & Young. 2018. Situación actual y retos del mieloma múltiple en España 2018. Ernst & Young.
- Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Piñeros, M., Znaor, A., Soerjomataram, I., and Bray, F. 2018. ‘ Global Cancer Observatory: Cancer today’. Global Cancer observatory: Cancer today. (https://gco.iarc.fr/today) Retrieved 3 January 2019.
- Fonseca, R., Abouzaid, S., Bonafede, M., Cai, Q., Parikh, K., Cosler, L., & Richardson, P. (2017). Trends in overall survival and costs of multiple myeloma, 2000–2014. Leukemia, 31(9), 1915–1921. https://doi.org/10.1038/leu.2016.380
- Goudet, S., Griffiths, P. L., Wainaina, C. W., Macharia, T. N., Wekesah, F. M., Wanjohi, M., Muriuki, P., & Kimani-Murage, E. (2018). Social value of a nutritional counselling and support program for breastfeeding in urban poor settings, Nairobi. BMC Public Health, 18, 424. https://doi.org/10.1186/s12889-018-5334-8
- Howell, D. A., Hart, R. I., Smith, A. G., Macleod, U., Patmore, R., Cook, G., & Roman, E. (2018). Myeloma: Patient accounts of their pathways to diagnosis. PLoS ONE, 13(4), e0194788. https://doi.org/10.1371/journal.pone.0194788
- Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., & Task Force, C. H. E. E. R. S. (2013). Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ (Clinical Research ed.), 346, f1049. https://doi.org/10.1136/bmj.f1049
- Instituto Nacional de Estadística. n.d. ‘ Índice de Precios de Consumo. Base 2016. Índices Nacionales: General y de Grupos ECOICOP.’ Retrieved 26 July 2017 (http://www.ine.es/jaxiT3/Tabla.htm?t=22553&L=0).
- International Myeloma Foundation. 2019. ‘ What is multiple myeloma?’ Retrieved 1 March 2019 (https://www.myeloma.org/what-is-multiple-myeloma).
- Jackson, G., Galinsky, J., Alderson, D. E. C., D'Souza, V. K., Buchanan, V., Dhanasiri, S., & Walker, S. (2019). Productivity losses in patients with newly diagnosed multiple myeloma following stem cell transplantation and the impact of maintenance therapy. European Journal of Haematology, 103(4), 393–401. https://doi.org/10.1111/ejh.13298
- Jefatura del Estado. (2002). Ley 41/2002, de 14 de Noviembre, Básica Reguladora de La Autonomía Del Paciente y de Derechos y Obligaciones En Materia de Información y Documentación Clínica. Vol. BOE-A-2002-22188.
- Jefatura del Estado. (2007). Ley 14/2007, de 3 de Julio, de Investigación Biomédica. Vol. BOE-A-2007-12945.
- Jones, R. B., Ashurst, E. J., Atkey, J., & Duffy, B. (2015). Older people going online: Its value and before-after evaluation of volunteer support. Journal of Medical Internet Research, 17(5), e122. https://doi.org/10.2196/jmir.3943
- Jones, C., Edwards, R. T., Windle, G., & Dementia, Imagination Research Team, and Others. (2014). Social return on investment analysis of an art Group for people with dementia. The Lancet, 384, S43.
- King, T. A., King, M. T., & White, K. J. (2017). Patient reported outcomes in optimizing myeloma patients' health-related quality of life. Seminars in Oncology Nursing, 33(3), 299–315. https://doi.org/10.1016/j.soncn.2017.05.006
- Kocaata, Z., Wilke, T., Fischer, F., Welte, R., & Einsele, H. (2022). Healthcare resource utilization and cost of patients with multiple myeloma in Germany: A retrospective claims data analysis. PharmacoEconomics - Open, 6(4), 619–628. https://doi.org/10.1007/s41669-022-00344-4
- Kolovos, S., Nador, G., Kishore, B., Streetly, M., Rabin, N. K., Chantry, A. D., Yong, K., Ashcroft, J., Bowcock, S., Drayson, M. T., Ramasamy, K., Prieto-Alhambra, D., Cyrus, C., Kassim Javaid, M., & Pinedo-Villanueva, R. (2019). Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs. Journal of Bone Oncology, 17, 100243. https://doi.org/10.1016/j.jbo.2019.100243
- Kumar, S. K., Dispenzieri, A., Lacy, M. Q., Gertz, M. A., Buadi, F. K., Pandey, S., Kapoor, P., Dingli, D., Hayman, S. R., Leung, N., Lust, J., McCurdy, A., Russell, S. J., Zeldenrust, S. R., Kyle, R. A., & Rajkumar, S. V. (2014). Continued improvement in survival in multiple myeloma: Changes in early mortality and outcomes in older patients. Leukemia, 28(5), 1122–1128. https://doi.org/10.1038/leu.2013.313
- Laing, C. M., & Moules, N. J. (2016). “It's not just camp!”: Understanding the meaning of children's cancer camps for children and families. Journal of Pediatric Oncology Nursing, 33(1), 33–44. https://doi.org/10.1177/1043454214563934
- Lophongpanit, P., Tongsiri, S., & Thongprasert, N. (2019). Social return on investment for patient treated by continuous ambulatory peritoneal Dialysis: A case study in Ubon Ratchathani Province, Thailand. ClinicoEconomics and Outcomes Research, 11, 569–578. https://doi.org/10.2147/CEOR.S217785
- Masters, R., Anwar, E., Collins, B., Cookson, R., & Capewell, S. (2017). Return on investment of public health interventions: A systematic review. Journal of Epidemiology and Community Health, 71(8), 827–834. https://doi.org/10.1136/jech-2016-208141
- McCaughan, D., Roman, E., Smith, A. G., Garry, A., Johnson, M., Patmore, R., Howard, M., & Howell, D. A. (2017). Determinants of hospital death in haematological cancers: Findings from a qualitative study. BMJ Supportive & Palliative Care, 8(1), 78–86. https://doi.org/10.1136/bmjspcare-2016-001289
- Merino, M., Ivanova, Y., Lorenzo, T. M., & Hidalgo-Vega, Á. (2022). Improving rheumatoid arthritis management within the Spanish National Health System: A social return on investment study. Clinical and Experimental Rheumatology, 40, 104–111.
- Merino, M., Ivanova, Y., Maravilla, P., & Hidalgo-Vega, Á. (2019). Valor social de la mejora del abordaje del mieloma múltiple en el Sistema Nacional de Salud’. in 39 Jornadas de Economía de la Salud - La transparencia es saludable - La importancia de la rendición de cuentas en Sanidad. Fundación Weber.
- Merino, M., Jiménez, M., Manito, N., Casariego, E., Ivanova, Y., González-Domínguez, A., Saturnino, M. S., Hidalgo-Vega, Á., & Blanch, C. (2020). The social return on Investment of a new approach to heart failure in the Spanish National Health System. ESC Heart Failure, 7(1), 130–138. https://doi.org/10.1002/ehf2.12535
- Merino, M., Lorenzo, T. M., Maravilla-Herrera, P., Ancochea, J., Sáenz, J. T. G., Hass, N., Molina, J., Peces-Barba, G., Trapero-Bertran, M., Carrero, J. A. T., & Hidalgo-Vega, Á. (2022). A social return on investment analysis of improving the management of chronic obstructive pulmonary disease within the Spanish National Healthcare System. International Journal of Chronic Obstructive Pulmonary Disease, 17, 1431–1442. https://doi.org/10.2147/COPD.S361700
- Moral Torres, E., Fernández, Ó. F., Rueda, P. C., Ruiz-Beato, E., Pérez, E. E., Estrada, R. M., Gómez-García, T., Jiménez, M., Hidalgo-Vega, Á., & Merino, M. (2020). Social value of a set of proposals for the ideal approach of multiple sclerosis within the Spanish National Health System: A social return on investment study. BMC Health Services Research, 20, 84. https://doi.org/10.1186/s12913-020-4946-8
- Moreau, P., San Miguel, J., Sonneveld, P., Mateos, M. V., Zamagni, E., Avet-Loiseau, H., Hajek, R., Dimopoulos, M. A., Ludwig, H., Einsele, H., Zweegman, S., Facon, T., Cavo, M., Terpos, E., Goldschmidt, H., Attal, M., Buske, C., & ESMO Guidelines Committee. (2017). Multiple myeloma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 28(suppl_4), iv52–iv61. https://doi.org/10.1093/annonc/mdx096
- Nicholls, J. (2017). Social return on investment—Development and convergence. Evaluation and Program Planning, 64, 127–135. https://doi.org/10.1016/j.evalprogplan.2016.11.011
- Nicholls, J., Lawlor, E., Neitzert, E., & Goodspeed, T. (2012). A guide to social return on investment ( 2nd ed.). The SROI Network. Accounting for Value.
- Oberoi, D. V., White, V. M., Seymour, J. F., Miles Prince, H., Harrison, S., Jefford, M., Winship, I., Hill, D. J., Bolton, D., Millar, J., Doo, N. W., Kay, A., & Giles, G. (2017). Distress and unmet needs during treatment and quality of life in early Cancer survivorship: A longitudinal study of haematological cancer patients. European Journal of Haematology, 99(5), 423–430. https://doi.org/10.1111/ejh.12941
- Ortega-Ortega, M., Montero-Granados, R., & Jiménez-Aguilera, J. d. D. (2018). Differences in the economic valuation and determining factors of informal care over time: The case of blood cancer. Gaceta Sanitaria, 32(5), 411–417. https://doi.org/10.1016/j.gaceta.2017.02.006
- Ouchveridze, E., Berger, K., & Mohyuddin, G. R. (2022). Value in myeloma care: Myth or reality. Current Hematologic Malignancy Reports. https://doi.org/10.1007/s11899-022-00669-1
- Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., Bringhen, S., Gay, F., Attal, M., Passera, R., Spencer, A., Offidani, M., Kumar, S., Musto, P., Lonial, S., … Moreau, P. (2015). Revised international staging system for multiple myeloma: A report from international myeloma working group. Journal of Clinical Oncology, 33(26), 2863–2869. https://doi.org/10.1200/JCO.2015.61.2267
- Parker, C., Berkovic, D., Ayton, D., Zomer, E., Liew, D., & Wei, A. (2022). Patient perceived financial burden in haematological malignancies: A systematic review. Current Oncology (Toronto, Ont.), 29(6), 3807–3824. https://doi.org/10.3390/curroncol29060305
- Piñeiro, D., Goretti, M. C. S. C., Gil, C. P., Paredes-Galán, E., Ruíz, R. G., Sestayo, R. L., Sellera, C. G., & Lamas, M. (2015). El Retorno Económico y Social de La E-Interconsulta de Cardiología En El Área de Vigo. ICEDE Working Paper Series, ISSN 2254–7487, 11, 1–28.
- Quiñoa-Salanova, C., Porta-Sales, J., Monforte-Royo, C., & Edo-Gual, M. (2019). The experiences and needs of primary family caregivers of patients with multiple myeloma: A qualitative analysis. Palliative Medicine, 33(5), 500–509. https://doi.org/10.1177/0269216319830017
- Ramsenthaler, C., Kane, P., Gao, W., Siegert, R. J., Edmonds, P. M., Schey, S. A., & Higginson, I. J. (2016). Prevalence of symptoms in patients with multiple myeloma: A systematic review and meta-analysis. European Journal of Haematology, 97(5), 416–429. https://doi.org/10.1111/ejh.12790
- Rhein-Main, M. G. (2009a). International survey—Myeloma treatment compliance 2009. Summary Report. Myeloma Euronet.
- Rhein-Main, M. G. (2009b). International survey—Myeloma treatment side effects and unmet patient needs 2009. Summary Report. Myeloma Euronet.
- Rood, J. A. J., Eeltink, C. M., van Zuuren, F. J., Verdonck-de Leeuw, I. M., & Huijgens, P. C. (2015). Perceived need for information of patients with Haematological malignancies: A literature review. Journal of Clinical Nursing, 24(3–4), 353–369. https://doi.org/10.1111/jocn.12630
- Scharlach, A. E. (2015). Estimating the value of volunteer-assisted community-based aging services: A case example. Home Health Care Services Quarterly, 34(1), 46–65. https://doi.org/10.1080/01621424.2014.999902
- Soto, I., Mateo, J., García-Diego, D.-A., Gil, B., Ruiz-Beato, E., Ivanova, Y., Lorenzo, T. M., Maravilla-Herrera, P., Hidalgo-Vega, Á., & Merino, M. (2022). The impact of improving Haemophilia a management within the Spanish National Healthcare System: A social return on investment analysis. BMC Health Services Research, 22, 115. https://doi.org/10.1186/s12913-021-07447-4
- Tuan, M. T. 2008. ‘ Measuring and/or estimating social value creation: Insights into eight integrated cost approaches’.
- Willis, E., Semple, A. C., & de Waal, H. (2018). Quantifying the benefits of peer support for people with dementia: A social return on investment (SROI) study. Dementia, 17(3), 266–278. https://doi.org/10.1177/1471301216640184
